drugset
drugset / Trial / NCT07025850

Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer

NCT07025850 ↗

Phase 1/2 Not yet recruiting 20 enrolled Fudan University Anyang Tumor Hospital · collab
NaSingle-groupOpen-labelTreatment

Summary

Efficacy Study of Digoxin Combined with Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer

Timeline

Start
2025-08-01
Primary completion
2027-01-01
Completion
2027-05-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified 0.5 mg Oral
Subject Fruquintinib Small molecule 5 mg Oral
Subject Tislelizumab Monoclonal antibody 200 mg Intravenous

Indications

colorectal carcinoma